Knowledge Distillery

Substitution for aspartic acid by glycine at position 614 in the spike (S) protein of severe acute respiratory syndrome coronavirus 2 appears to…

SARS-CoV-2 infections and hospital admissions for COVID-19 increased rapidly in the South East region of England in November and December 2020,…

The efficacy of two injections of the SARS-CoV-2 spike mRNA vaccines (BNT162b2 [Pfizer] and mRNA-1273 [Moderna]) in preventing symptomatic SARS-CoV-2…

As mass vaccination campaigns against COVID-19 commence worldwide, vaccine effectiveness needs to be assessed for a range of outcomes across diverse…

Assessment of the safety and efficacy of vaccines against the SARS-CoV-2 in different populations is essential, as is investigation of the efficacy…

Coronavirus disease have been reported to be associated with several neurological manifestations such as stroke, Guillain-Barré syndrome,…

The coronavirus spike glycoprotein, located on the virion surface, is the key mediator of cell entry and the focus for development of protective…

The impact of the COVID‐19 pandemic on PD patients is yet to be determined.

The authors conducted a longitudinal case-control 18F-FDG-PET study in patients diagnosed with COVID-19-related encephalopathy.

The effects of the COVID‐19 pandemic on telemedical care have not been described on a national level. Thus, the authors investigated the medical…

This nationwide study assessed the impact of the pandemic on stroke hospitalisation rates, patient characteristics, and 30‐day case fatality rates.

Emergence of SARS-CoV-2 causing COVID-19 prompted the need to gather information on clinical outcomes and risk factors associated with morbidity and…